Thomas A. Mitro
2014
In 2014, Thomas A. Mitro earned a total compensation of $2.4M as President & Chief Operating Officer at Aerie Pharmaceuticals, a 26% decrease compared to previous year.
Compensation breakdown
| Bonus | $237,500 |
|---|---|
| Option Awards | $1,831,168 |
| Salary | $380,000 |
| Total | $2,448,668 |
Mitro received $1.8M in option awards, accounting for 75% of the total pay in 2014.
Mitro also received $237.5K in bonus and $380K in salary.
Rankings
In 2014, Thomas A. Mitro's compensation ranked 3,731st out of 13,032 executives tracked by ExecPay. In other words, Mitro earned more than 71.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,731 out of 13,032 | 71st |
Division Manufacturing | 1,315 out of 4,966 | 74th |
Major group Chemicals And Allied Products | 428 out of 1,686 | 75th |
Industry group Drugs | 332 out of 1,365 | 76th |
Industry Biological Products, Except Diagnostic Substances | 53 out of 236 | 78th |
Source: SEC filing on April 29, 2016.
Mitro's colleagues
We found three more compensation records of executives who worked with Thomas A. Mitro at Aerie Pharmaceuticals in 2014.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019